Skip to main content

Month: July 2024

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

New full-range solution adds bone-sparing baseplate, peripheral fixation, and glenosphere options to proven reverse shoulder prosthesis (RSP®) glenoid baseplate while maintaining hallmark simplicity and efficiency. First surgery using AltiVate Reverse® Glenoid System conducted by Dr. Mark Frankle at Tampa General Hospital on Monday, July 8, 2024. AUSTIN, TX, July 12, 2024 (GLOBE NEWSWIRE) —  Enovis™ (NYSE: ENOV), a leading innovator in shoulder arthroplasty systems that help improve quality of life and restore movement, introduced today the one-tray AltiVate Reverse® Glenoid System, which expands the glenoid implant offering of the market-leading AltiVate Reverse to include modular, augmented baseplates. Based on the Company’s central screw fixation design with a minimum of 10 years of clinical follow-up1, the AltiVate Reverse®...

Continue reading

Syntec Optics (Nasdaq: OPTX) to Manufacture over $1M in Advanced Optics for Next Generation U.S. Defense Integrated Optics System

Enabling higher accuracy for the Smart Optics System ROCHESTER, NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) — Syntec Optics (Nasdaq: OPTX), a mission-critical supplier of scientific and technical instruments and defense and aerospace optics to OEMs, today announced it is scheduling to manufacture orders for two critical optics that fit in the next generation military optics systems. Such new systems provided by the customer integrate several advanced technologies, including a variable magnification optic, laser rangefinder, visible and infrared lasers, a digital display overlay, and several other sensing and calculating abilities. Syntec’s mission-critical optics deliveries of nearly $900,000 are scheduled for twelve months. Orders will likely increase in the following years and are anticipated to last over a decade. Syntec...

Continue reading

Shineco Announces Pricing of $2 Million Underwritten Public Offering

Beijing, July 12, 2024 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any. The offering is expected to close on July 15, 2024, subject to satisfaction of customary closing conditions. EF Hutton LLC...

Continue reading

Unrivaled Brands Wins Another Key Court Battle Against People’s California, LLC

SANTA ANA, Calif., July 12, 2024 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm Holdings,” “we” or “us”), a cannabis company with subsidiaries operating throughout California, announces two more legal victories by its wholly owned subsidiary, Unrivaled Brands, Inc. (“Unrivaled”), against People’s California, LLC (“People’s”). This time, Unrivaled successfully defended an ex parte application brought by People’s, with the Court denying People’s request for a multi-million dollar judgment to be entered against Unrivaled. At the same hearing, the Court granted Unrivaled’s application for a preliminary injunction barring People’s from attempting to foreclose on a building owned by an affiliated entity and invalidating a prior foreclosure attempt by People’s, following a previously granted Temporary Restraining...

Continue reading

Navitas in Japan: Next-gen AI Data Center, EV, Industrial, and Fast Charging SiC and GaN Showcased at Techno-Frontier

Navitas and partner J Rep to provide leading solutions to reduce time to market and simplicity of designs, with the highest system efficiency, reliability, and power density.Navitas in Japan: Next-gen AI Data Center, EV, Industrial, and Fast Charging SiC and GaN Showcased at Techno-FrontierNavitas and partner J Rep to provide leading solutions to reduce time to market and simplicity of designs, with the highest system efficiency, reliability, and power density.TORRANCE, Calif., July 12, 2024 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced it will team up with its Japanese sales and marketing partner, J Rep, at Japan’s largest power electronics trade show...

Continue reading

AMN Healthcare to Hold Second Quarter 2024 Earnings Conference Call on Thursday, August 8, 2024

DALLAS, July 12, 2024 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2024 financial results and third quarter 2024 outlook on Thursday, August 8, 2024, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare’s investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail address. A PIN will be provided to you with dial-in instructions. If you lose track of these details, please re-register at the conference call link...

Continue reading

Power Tools Market to Surpass USD 67.64 Billion by 2031 | Skyquest Technology

Westford, USA, July 12, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global power tools market will attain a value of USD 67.64 billion by 2031, with a CAGR of 5.8% during the forecast period (2024-2031). The power tools market is led by different factors and had double-digit growth figures in developed and developing countries’ markets. As a discrete part of the driving force, the surge can be attributed to an evident upsurge in the demand for public infrastructure schemes, in countries that are referred to as emerging economies. These growing countries with large populations, growing at a rapid rate, are putting a lot of money into infrastructure development. As a result, the demand for construction or any related tools powering these activities are also increasing. Download a detailed overview: https://www.skyquestt.com/sample-request/power-tools-market Browse...

Continue reading

Sify Technologies to announce Financial Results for First Quarter FY 2024-25 on Friday, July 19, 2024

CHENNAI, India, July 12, 2024 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the First quarter ended June 30, 2024 on Friday, July 19, 2024 before the market opens.  In conjunction with the announcement, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board, Mr. M P Vijay Kumar, Executive Director & Group CFO and Mr. Kamal Nath, Chief Executive Officer. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International), which will also be simultaneously broadcast live over the Internet...

Continue reading

Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference

Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces its participation in the upcoming Psychedelic Medicine – Israel 2024 conference. This event will take place in Tel Aviv, Israel from July 28th to 30th, bringing together leading experts and researchers from around the world in the field of psychedelic medicine. Clearmind’s CEO, Adi Zullof-Shani, Ph.D., will present a compelling talk titled “5-Methoxy-2-Aminoindane (MEAI) as a Binge Behavior Regulator.” This presentation is scheduled for Monday, July 29th, in the Research Presentations 1 session, from 9:00 a.m. to 10:40...

Continue reading

TRESU Investment Holding A/S – adjustment to full year 2024 guidance

TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 07.2024 12.07.2024 TRESU Investment Holding A/S – adjustment to full year 2024 guidance. TRESU Investment Holding A/S today announces an adjustment to full year guidance for 2024 mainly driven by slow market demands and postponed decisions from customers. We have experienced a temporary slowdown in market activities in our System business segment mainly driven by a slowdown in Packaging and lower demands in Corrugated. We expect to return to growth at the end of 2024. In addition, we have seen postponed customers’ investment decisions in the machines & unit segment, expected to be taken now in the second half of the year. The Customer Care business is expected to grow further and will be at plan level. Implemented operational initiatives are showing good results and have improved underlying...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.